These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
137 related articles for article (PubMed ID: 6678867)
21. Determination of 1-(2-chloroethyl)-3-(2,6-dioxo-3-piperidyl)-1-nitrosourea in plasma by negative chemical ionization mass spectrometry. Smith RG; Cheung LK; Feun LG; Loo TL Biomed Mass Spectrom; 1983 Jul; 10(7):404-7. PubMed ID: 6616018 [TBL] [Abstract][Full Text] [Related]
22. DNA damage and repair in L1210 cells exposed to 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. Hilton J; Bowie DL; Gutin PH; Zito DM; Walker MD Cancer Res; 1977 Jul; 37(7 Pt 1):2262-6. PubMed ID: 861950 [TBL] [Abstract][Full Text] [Related]
23. Intracarotid infusion of PCNU (NSC: 95466): preclinical toxicological study in dogs. Goumnerova L; Richard MT; Addison D; Montpetit V; Stewart DJ J Neurooncol; 1987; 5(3):205-9. PubMed ID: 3681384 [TBL] [Abstract][Full Text] [Related]
24. Response of exponentially growing, stationary-phase, and synchronized cultured human colon carcinoma cells to treatment with nitrosourea derivatives. Drewinko B; Barlogie B; Freireich EJ Cancer Res; 1979 Jul; 39(7 Pt 1):2630-6. PubMed ID: 445465 [TBL] [Abstract][Full Text] [Related]
25. Sensitivity of human cell strains having different abilities to repair O6-methylguanine in DNA to inactivation by alkylating agents including chloroethylnitrosoureas. Scudiero DA; Meyer SA; Clatterbuck BE; Mattern MR; Ziolkowski CH; Day RS Cancer Res; 1984 Jun; 44(6):2467-74. PubMed ID: 6722789 [TBL] [Abstract][Full Text] [Related]
26. Studies on recovery from chemically induced damage in mammalian cells. Barranco SC; Novak JK; Humphrey RM Cancer Res; 1975 May; 35(5):1194-204. PubMed ID: 47265 [TBL] [Abstract][Full Text] [Related]
27. Biological and biochemical properties of 1-(2-chloroethyl)-3-(beta-D-glucopyranosyl)-1-nitrosourea (NSC D 254157), a nitrosourea with reduced bone marrow toxicity. Fox PA; Panasci LC; Schein PS Cancer Res; 1977 Mar; 37(3):783-7. PubMed ID: 138478 [TBL] [Abstract][Full Text] [Related]
28. Inhibition of the hepatic O6-alkylguanine-DNA alkyltransferase in vivo by pretreatment with antineoplastic agents. Meer L; Schold SC; Kleihues P Biochem Pharmacol; 1989 Mar; 38(6):929-34. PubMed ID: 2930593 [TBL] [Abstract][Full Text] [Related]
29. A comparison of the lethal effects of three nitrosourea derivatives on cultured human lymphoma cells. Drewinko B; Loo TL; Gottlieb JA Cancer Res; 1976 Feb; 36(2 Pt 1):511-5. PubMed ID: 1260749 [TBL] [Abstract][Full Text] [Related]
30. Effect of a new bifunctional nitrosoureido derivative on human colorectal tumor xenografts. Kopper L; Lapis K; Csányi E; Horváth T Anticancer Res; 1981; 1(4):229-33. PubMed ID: 7345967 [TBL] [Abstract][Full Text] [Related]
31. Anticancer nitrosoureas: investigations on antineoplastic, toxic and neoplastic activities. Eisenbrand G IARC Sci Publ; 1984; (57):695-708. PubMed ID: 6533062 [TBL] [Abstract][Full Text] [Related]
32. Lysis of human promyelocytic HL-60 cells by amphotericin B in combination with 2-chloroethyl-1-nitrosoureas: role of the carbamoylating activity of nitrosoureas. Brajtburg J; Elberg S; Schechtman KB; Medoff G Cancer Res; 1990 Jun; 50(11):3274-8. PubMed ID: 2334920 [TBL] [Abstract][Full Text] [Related]
33. In vitro cytotoxicity and differential cellular sensitivity of derivatives of diamino acids. II. N1-methyl, N1-allyl, N1-(2-chloroethyl) and N1-propargyl nitrosoureas. Dulude H; Salvador R; Gallant G Anticancer Res; 1995; 15(3):853-8. PubMed ID: 7645970 [TBL] [Abstract][Full Text] [Related]
34. Comparative effects of three nitrosourea derivatives on mammalian cell cycle progression. Tobey RA; Crissman HA Cancer Res; 1975 Feb; 35(2):460-70. PubMed ID: 1167349 [TBL] [Abstract][Full Text] [Related]
35. Acute leukemia occurring after radiotherapy and chemotherapy with a nitrosourea, PCNU. Shepard KV; Larson R; Le Beau MM; Leichman L; Levin B Invest New Drugs; 1988 Jun; 6(2):121-4. PubMed ID: 3170132 [TBL] [Abstract][Full Text] [Related]
36. Investigation of resistance to DNA cross-linking agents in 9L cell lines with different sensitivities to chloroethylnitrosoureas. Bodell WJ; Gerosa M; Aida T; Berger MS; Rosenblum ML Cancer Res; 1985 Aug; 45(8):3460-4. PubMed ID: 3860285 [TBL] [Abstract][Full Text] [Related]
37. Repair of DNA alkylation induced in L1210 leukemia and murine bone marrow by three chloroethylnitrosoureas. Ahlgren JD; Green DC; Tew KD; Schein PS Cancer Res; 1982 Jul; 42(7):2605-8. PubMed ID: 6211225 [TBL] [Abstract][Full Text] [Related]
38. alpha-Difluoromethylornithine effects on nitrosourea-induced cytotoxicity and crosslinking in a methylation excision repair positive (MER+) human cell line. Ducore JM Biochem Pharmacol; 1987 Jul; 36(13):2169-74. PubMed ID: 3111477 [TBL] [Abstract][Full Text] [Related]
39. (2-Chloroethyl)nitrosourea congeners of amino acid amides. Suami T; Kato T; Takino H; Hisamatsu T J Med Chem; 1982 Jul; 25(7):829-32. PubMed ID: 7108898 [TBL] [Abstract][Full Text] [Related]
40. PCNU and recurrent childhood brain tumors. Allen JC; Hancock C; Walker R; Tan C J Neurooncol; 1987; 5(3):241-4. PubMed ID: 3681386 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]